Wolferstans have been recogised by Cancer Research UK after facilitating over £678,657 worth of gifts from people choosing to leave a legacy to the charity in their Will.
Wolferstans, on North Hill, was presented with a Silver certificate by Legacy Partnerships Manager Annabel Coakley, to acknowledge the firm’s commitment to the cause.
The firm has been offering Cancer Research UK’s Free Will Service to people aged 55 and over in Plymouth for the past 17 years, giving guidance and support to those wishing to write a Will or update an existing one.
Gifts in Wills fund over a third of the charity’s life-saving research. Without them, Cancer Research UK would not be able to undertake the vital research that will one day beat cancer for patients in Plymouth and across the UK.
Partner and Head of Wills and Probate, Gemma Smith, said:
“We were very happy for Annabel to come and update us on the charity’s work and to present our certificate, which now has pride of place on our wall! We all understand the importance of charitable giving and are committed to supporting the work of Cancer Research UK, which as we all know is doing sterling work, much of which Annabel explained is happening right here locally in Plymouth and Exeter.”
A legacy gift can be anything someone wishes to leave in their Will. Traditionally this is money, but it could be anything that has a monitory value such as an estate or specific item.
Clare Moore, Director of Legacies at Cancer Research UK, said:
“We all reach a stage at some point in our lives where we start to look ahead and consider what will happen to our financial affairs in the future, when we may no longer be around.”
“We are grateful to Wolferstans for the expertise and sensitivity they show in providing clear information and guidance to help people in Plymouth make the best choices for them.”
“It’s thanks to these vital donations and the generosity of our supporters that we are able to keep making progress in the fight against the disease.”
Together with their supporters, Cancer Research UK has played a role in developing 8 out the world’s top 10 cancer drugs; helped prove the link between tobacco and cancer, preventing millions of deaths worldwide and were a key player in the development of radiotherapy, which benefits more than 130,000 patients every year in the UK.
For more information, visit cruk.org/freewillservice